Medicines (MDCO) News Today

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis

Source

Source	Headline
	No link between Ozempic, Wegovy and suicide, EU drug regulators say marketbeat.com - April 12 at 1:50 PM
	Mitsui and Rohto to buy $594 mln Chinese medicines company Eu Yan Sang reuters.com - April 4 at 5:33 AM
	FIXX Stock Earnings: Homology Medicines Beats EPS for Q4 2023 investorplace.com - March 15 at 11:02 PM
	Medicine in Britain, c.1250 to the present day bbc.co.uk - February 23 at 1:49 PM
	Revolution Medicines started at outperform with $41 stock price target at Wedbush marketwatch.com - January 4 at 11:09 AM
	Warming on cancer risk in Chinese medicines dailymail.co.uk - December 30 at 10:08 AM
	Gene modified chickens 'lay medicines' bbc.com - December 15 at 9:51 AM
	AbbVie Announces U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma prnewswire.com - November 27 at 7:02 AM
	Pfizer and Sanofi shares fall, which one to scoop up? (MDCO) marketbeat.com - November 7 at 6:17 AM
	EU plans for countries to share medicines in case of shortage ft.com - October 23 at 9:56 AM
	CVS To Remove Some Cold, Cough Medicines With Phenylephrine rttnews.com - October 20 at 3:10 PM
	How Revolution Medicines chased down EQRx's $1 billion cash prize bizjournals.com - October 4 at 11:02 AM
	Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares benzinga.com - October 4 at 11:02 AM
	Could Ely Lilly Be the Best Pharma Stock to Own Now and Forever? (MDCO) marketbeat.com - September 19 at 7:05 AM
	Medicines360’s long and winding, $82 million road to create and distribute $50 birth control marketbeat.com - September 1 at 3:49 PM
	Approval of an Orphan Disease Application for its lead product, the Cellspan Esophageal Implant by the European Medicines Agency prnewswire.com - August 21 at 9:03 AM
	European Medicines Agency Accepts Iveric Bio's Marketing Authorization Application for Avacincaptad Pegol for Geographic Atrophy prnewswire.com - August 17 at 8:01 PM
	7 Best Cancer Stocks to Invest in Now (MDCO) marketbeat.com - July 31 at 11:59 AM
	Everest Medicines Announces Commercial Launch and First Prescription for XERAVA® in China markets.businessinsider.com - July 26 at 9:51 PM
	EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs cnbc.com - July 11 at 5:11 PM
	Point72/Steven Cohen Increases Stake in Praxis Precision Medicines to 8.9% investing.com - June 26 at 5:06 PM
	Does Pet Insurance Cover Medication? marketwatch.com - June 20 at 11:14 AM
	Everest Medicines Receives Full Upfront Payment from Gilead for Trodelvy-Related Transaction, Boosting Pro Forma Cash Reserves prnewswire.com - March 26 at 9:47 PM
	Medicines regulator seeks to shake off UK ‘isolationist’ label with new alliance ft.com - March 19 at 4:14 PM
	Bioprojet: WAKIX® (pitolisant) receives approval for the treatment of narcolepsy in children over 6 years of age, a rare, under-diagnosed condition prnewswire.com - March 15 at 3:39 AM
	Everest Medicines Announces Silicon Valley Bank Developments Have Minimal Impact on Company prnewswire.com - March 12 at 8:46 PM
	Pharma Mafia Wants To Conquer Cannabis: Can You Patent A Plant? Jazz Is Trying benzinga.com - March 7 at 1:54 PM
	Revolution Medicines' Early-Data Validation For Cancer Program Wins Price Target Boost By This Analyst benzinga.com - February 28 at 4:56 PM
	Why Revolution Medicines Shares Are Trading Higher Today benzinga.com - February 28 at 4:56 PM
	Thinking about buying stock in Revolution Medicines, Progyny, LM Funding America, Vertex Energy, or Hims & Hers Health? prnewswire.com - February 28 at 8:53 AM
	Blueprint Medicines Presents Registrational Data from PIONEER Trial of AYVAKIT® (avapritinib) in Patients with Indolent Systemic Mastocytosis at 2023 AAAAI Annual Meeting prnewswire.com - February 26 at 4:02 PM
	Merck: CHMP Recommends Against Approval Of Lagevrio For Treatment Of Certain Adults With COVID-19 markets.businessinsider.com - February 24 at 10:31 AM
	Global Personalized Medicines Strategic Market Report 2023: Market to Surpass $740 Billion by 2030 - Genomics to Dictate Advancement of Personalized Medicines prnewswire.com - February 16 at 11:09 PM
	FDA Slaps Partial Clinical Hold On Blueprint Medicines' Early-Stage Solid Tumor Study benzinga.com - February 10 at 9:51 AM
	AstraZeneca Forecasts Growth In 2023 Earnings, Revenue Despite Fall In COVID-19 Products, Plans To Deliver 15 New Medicines This Decade benzinga.com - February 9 at 9:50 AM
	Drugmakers Raise Prices on Nearly 1,000 Medicines wsj.com - February 2 at 9:19 AM
	Psychiatry And Business Collaborate: European Psychedelics Trial Tackles Alcohol Addiction benzinga.com - January 20 at 8:15 PM
	AbbVie, Eli Lilly Leave UK's Voluntary Medicines Pricing Agreement Over Increasing Prices benzinga.com - January 17 at 6:43 AM
	Autolomous will digitale Lösungen für Center for Breakthrough Medicines zur Optimierung und Automatisierung der Herstellung von Zell- und Gentherapien bereitstellen prnewswire.com - January 13 at 1:41 AM
	Belharra Therapeutics Announces Broad Collaboration with Genentech to Discover and Develop Novel Medicines Across Multiple Therapeutic Areas financialpost.com - January 4 at 11:55 AM
	Everest Medicines Commences Operations at its mRNA Vaccine Manufacturing Facility, Accelerating Evolution to a Fully-Integrated Biopharma prnewswire.com - December 27 at 7:29 PM
	Calliditas to host fireside chat with its China commercial partner, Everest Medicines prnewswire.com - December 9 at 2:18 AM
	Revolution Medicines: Highly Differentiated Offering Gaining Traction seekingalpha.com - December 7 at 5:06 PM
	The European Medicines Agency's Updated Guidelines for JAK Inhibitors in Rheumatoid Arthritis - A Cause for Concern? Spherix Investigates prnewswire.com - December 7 at 5:47 AM
	European Medicines Agency Accepts Tofersen Marketing Authorization Application to Treat Rare, Genetic Form of ALS financialpost.com - December 5 at 7:36 AM
	European Official Says COVID-19 Booster Uptake Disappointing In The Region benzinga.com - November 25 at 12:31 PM
	Everest Medicines Announces New Drug Application Acceptance by China NMPA for Nefecon for the Treatment of Primary IgA Nephropathy prnewswire.com - November 14 at 7:30 PM
	Sensorium Therapeutics Closes $30 Million Series A to Transform Mental Health Treatment with Nature-Inspired Psychoactive Medicines prnewswire.com - November 8 at 6:57 AM
	Blueprint Medicines Stock Gets Price Target Cut Amid Lower Than Expected Ayvakit Uptake benzinga.com - November 2 at 3:48 PM
	Blueprint Medicines PT Lowered to $58 at Barclays investing.com - November 2 at 7:28 AM

Get Medicines News Delivered to You Automatically

Strange new buyer driving up gold (Ad)

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

MDCO Media Mentions By Week

MDCO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MDCO
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

MDCO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MDCO Articles
This Week
▼
1

0
▲
MDCO Articles
Average Week

Get Medicines News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:MDCO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Medicines (MDCO) News Today

MDCO Media Mentions By Week

MDCO Media Sentiment

MDCO News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info